The role of the epidermis and the mechanism of action of occlusive dressings in scarring

Wound Repair and Regeneration

Volumn 19, Issue SUPPL. 1, 2011, Pages s16-s21

  Mustoe, Thomas A ^a   Gurjala, Anandev ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ELECTRON MICROSCOPY; EPIDERMIS; HISTOLOGY; HUMAN; HYDRATION; HYPOTHESIS; IN VITRO STUDY; INFLAMMATION; MOLECULAR INTERACTION; NONHUMAN; OCCLUSIVE DRESSING; PRIORITY JOURNAL; REGULATORY MECHANISM; SCAR FORMATION; SKIN FIBROSIS; SKIN WATER LOSS; SKINFOLD THICKNESS;

EID: 79960956047     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00709.x     Document Type: Article

References (37)

1. Brown JJ, Bayat A., Genetic susceptibility to raised dermal scarring. Br J Dermatol 2009; 161: 8-18.
2. Derderian CA, Bastidas N, Lerman OZ, et al,. Mechanical strain alters gene expression in an in vitro model of hypertrophic scarring. Ann Plast Surg 2005; 55: 69-75; discussion 75. (Pubitemid 40884801)
3. van der Veer WM, Bloemen MC, Ulrich MM, Molema G, van Zuijlen PP, Middelkoop E, Niessen FB., Potential cellular and molecular causes of hypertrophic scar formation. Burns 2009; 35: 15-29.
4. Brown DL, Kao WW, Greenhalgh DG., Apoptosis down-regulates inflammation under the advancing epithelial wound edge: delayed patterns in diabetes and improvement with topical growth factors. Surgery 1997; 121: 372-80. (Pubitemid 27184960)
5. Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J., Hypertrophic burn scars: analysis of variables. J Trauma 1983; 23: 895-8. (Pubitemid 13022400)
6. Koskela A, Engstrom K, Hakelius M, Nowinski D, Ivarsson M., Regulation of fibroblast gene expression by keratinocytes in organotypic skin culture provides possible mechanisms for the antifibrotic effect of reepithelialization. Wound Rep Regen 2010; 18: 452-9.
7. Tsai JC, Feingold KR, Crumrine D, Wood LC, Grunfeld C, Elias PM., Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis. Arch Dermatol Res 1994; 286: 242-8. (Pubitemid 24124336)
8. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR., Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90: 482-7.
9. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold KR., Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 1994; 103: 834-8.
10. Man MQ, Wood L, Elias PM, Feingold KR., Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF type I receptor deficient mice. Exp Dermatol 1999; 8: 261-6. (Pubitemid 29370850)
11. Roupe KM, Nybo M, Sjobring U, Alberius P, Schmidtchen A, Sorensen OE., Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol 2010; 130: 1167-77. Epub Sep 3, 2009.
12. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M., Keratins and the keratinocyte activation cycle. J Invest Dermatol 2001; 116: 633-40. (Pubitemid 32467639)
13. Kunii T, Hirao T, Kikuchi K, Tagami H., Stratum corneum lipid profile and maturation pattern of corneocytes in the outermost layer of fresh scars: the presence of immature corneocytes plays a much more important role in the barrier dysfunction than do changes in intercellular lipids. Br J Dermatol 2003; 149: 749-56. (Pubitemid 37411994)
14. Ahn ST, Monafo WW, Mustoe TA., Topical silicone gel: a new treatment for hypertrophic scars. Surgery 1989; 106: 781-6; discussion 786-787.
15. Andriessen MP, Niessen FB, Van de Kerkhof PC, Schalkwijk J., Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study. J Pathol 1998; 186: 192-200. (Pubitemid 28467830)
16. Machesney M, Tidman N, Waseem A, Kirby L, Leigh I., Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol 1998; 152: 1133-41. (Pubitemid 28221864)
17. Suetake T, Sasai S, Zhen YX, Ohi T, Tagami H., Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars. Arch Dermatol 1996; 132: 1453-8. (Pubitemid 26424545)
18. Perkins K, Davey RB, Wallis KA., Silicone gel: a new treatment for burn scars and contractures. Burns Incl Therm Inj 1983; 9: 201-4. (Pubitemid 13121622)
19. Quinn KJ, Evans JH, Courtney JM, Gaylor JD, Reid WH., Non-pressure treatment of hypertrophic scars. Burns Incl Therm Inj 1985; 12: 102-8. (Pubitemid 16174197)
20. Ahn ST, Monafo WW, Mustoe TA., Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg 1991; 126: 499-504.
21. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UE., International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110: 560-71. (Pubitemid 34815962)
22. Tandara AA, Mustoe TA., The role of the epidermis in the control of scarring: evidence for mechanism of action for silicone gel. J Plast Reconstr Aesthet Surg 2008; 61: 1219-25.
23. Morris DE, Wu L, Zhao LL, Bolton L, Roth SI, Ladin DA, Mustoe TA., Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 1997; 100: 674-81. (Pubitemid 27381074)
24. Marcus JR, Tyrone JW, Bonomo S, Xia Y, Mustoe TA., Cellular mechanisms for diminished scarring with aging. Plast Reconstr Surg 2000; 105: 1591-9. (Pubitemid 30191260)
25. O'Shaughnessy KD, De La Garza M, Roy NK, Mustoe TA., Homeostasis of the epidermal barrier layer: a theory of how occlusion reduces hypertrophic scarring. Wound Rep Regen 2009; 17: 700-8.
26. Morasch MD, Gurjala AN, Washington E, Chiou AC, Simonetti OP, Finn JP, Yao JS., Cross-sectional magnetic resonance angiography is accurate in predicting degree of carotid stenosis. Ann Vasc Surg 2002; 16: 266-72. (Pubitemid 34761155)
27. Saulis AS, Chao JD, Telser A, Mogford JE, Mustoe TA., Silicone occlusive treatment of hypertrophic scar in the rabbit model. Aesthet Surg J 2002; 22: 147-53.
28. Kloeters O, Schierle C, Tandara A, Mustoe TA., The use of a semiocclusive dressing reduces epidermal inflammatory cytokine expression and mitigates dermal proliferation and inflammation in a rat incisional model. Wound Rep Regen 2008; 16: 568-75. (Pubitemid 352000322)
29. Tandara AA, Kloeters O, Mogford JE, Mustoe TA., Hydrated keratinocytes reduce collagen synthesis by fibroblasts via paracrine mechanisms. Wound Rep Regen 2007; 15: 497-504. (Pubitemid 47087642)
30. Gurjala AN, Liu WR, Mogford JE, Procaccini PS, Mustoe TA., Age-dependent response of primary human dermal fibroblasts to oxidative stress: cell survival, pro-survival kinases, and entrance into cellular senescence. Wound Rep Regen 2005; 13: 565-7.
31. Gallant-Behm CL, Du P, Lin SM, Marucha PT, DiPietro LA, Mustoe TA,. Epithelial regulation of mesenchymal tissue behavior. J Invest Dermatol 2011; 131: 892-9.
32. Mogford JE, Liu WR, Reid R, Chiu CP, Said H, Chen SJ, Harley CB, Mustoe TA., Adenoviral human telomerase reverse transcriptase dramatically improves ischemic wound healing without detrimental immune response in an aged rabbit model. Hum Gene Ther 2006; 17: 651-60. (Pubitemid 43967868)
33. Reid RR, Mogford JE, Butt R, deGiorgio-Miller A, Mustoe TA., Inhibition of procollagen C-proteinase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Rep Regen 2006; 14: 138-41.
34. Mustoe TA., Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg 2008; 32: 82-92.
35. Sisco M, Kryger ZB, O'Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, Roy NK, Dean NM, Mustoe TA., Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Rep Regen 2008; 16: 661-73.
36. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC., Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004; 45: 4293-301. (Pubitemid 39564653)
37. Pflugfelder SC, de Paiva CS, Tong L, Luo L, Stern ME, Li DQ., Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease. Ocul Surf 2005; 3 (4 Suppl): S154-7.